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Introduction
Fluorescence spectroscopy (FS) is a non-invasive tech-
nique which can be used to distinguish normal from
abnormal tissue and can identify at an early stage dysplas-
tic changes as well as provide clinical screening in real
time without the need for tissue removal or processing.
Modalities
All tissues fluoresce due to the presence of fluorescent
chromophores (fluorophores) within them. The com-
monly fluorophores are NADH, collagen, elastin and co-
factors such as flavins (FAD, FMN). FS can detect these
substances and provide characteristic spectra that reflect
biochemical changes within the tissues. There are three
main ways to obtain fluorescence, autofluorescence
(induced by UV light) Laser-induced and enhanced/dye
which can be by either topical or systemic application of
5-aminolaevulinic acid (5-ALA). Dysplastic and malig-
nant tissues, as well as having different spectral character-
istics, tend to have increased red fluorescence and
decreased green fluorescence. Therefore, significant
increase in the red/green fluorescence ratio is an accurate
predictor of dysplasia and malignancy.
Instrumentation in FS consists of a light source such as
lamps, a fluorescence interference filter and an optical
endoscope for both illumination and detection of the tis-
sue fluorescence. The eyepiece of the endoscope is con-
nected to a highly sensitive single chip, charge-coupled
device (CCD) colour camera integrated with red/green/
blue (RGB) mosaic filter and the images can be captured
by a frame-grabber fitted with an analogue/digital con-
verter (ADC) and analyzed and displayed using a software
of a personal computer.
Various clinical studies have been conducted to demon-
strate the accuracy of this method in detecting dysplastic
lesions. Gillenwater et al found a sensitivity of 88% and a
specificity of 100% using autofluorescence in the oral
mucosa, Wang et al found a sensitivity of 81.25% and a
specificity of 93.75% with a positive predictive value of
92.86%, Van Staveren et al found a sensitivity of 86% and
specificity of 100%, Zheng et al found a sensitivity of 95%
and specificity of 97%, Sharwani et al found a sensitivity
of 83–90% and specificity of 89% by applying 5-ALA in
the form of mouthrinse prior to fluorescence imaging.
Conclusion
FS is a valuable tool which can provide real-time diagnosis
of premalignant/malignant lesions, it is cost effective and
can certainly improve the patient's prognosis.
from 1st Scientific Meeting of the Head and Neck Optical Diagnostics Society
London, UK. 14 March 2009
Published: 28 July 2009
Head & Neck Oncology 2009, 1(Suppl 1):P3 doi:10.1186/1758-3284-1-S1-P3
<supplement> <title> <p>1<sup>st </sup>Scientific Meeting of the Head and Neck Optical Diagnostics Society</p> </title> <editor>Colin Hopper, Adel K El-Naggar, Tahwinder Upile, Waseem Jerjes and HJCM Sterenborg</editor> <sponsor> <note>Publication of this supplement was made possible with support from KARL STORZ Endoskope</note> </sponsor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1758-3284-1-S1-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1758-3284-1-S1-info.pdf</url> </supplement>
This abstract is available from: http://www.headandneckoncology.org/content/1/S1/P3
© 2009 Toursounidis et al; licensee BioMed Central Ltd. 
